Amrize Ltd AMRZ
NYSE · United States · Non-Energy Minerals
$36.65-0.74 (-1.98%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Amrize's (AMRZ) 2027 period should be better than 2026, with earnings growth returning to its mid-te
Amrize shares have dropped sharply so far this year, which puts the focus squarely on whether the current price is still aligned with the cash the business is expected to generate over time. With the stock now trading well below where it started the year, the central question is how that market move lines up with the intrinsic value suggested by its cash flows. Year to date, Amrize has fallen 28.5%, which puts recent price weakness directly up against what its underlying cash flows may be...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.